Login / Signup

Predicting the effect of sirolimus on disease activity in patients with systemic lupus erythematosus using machine learning.

Dong-Dong WangYa-Feng LiCun ZhangSu-Mei HeXiao Chen
Published in: Journal of clinical pharmacy and therapeutics (2022)
This study was the first time to predict the effect of sirolimus on disease activity in patients with SLE and in order to achieve better therapeutic effect maintaining a concentration of 8-10 ng/ml sirolimus for at least 6.12 months was necessary.
Keyphrases
  • disease activity
  • systemic lupus erythematosus
  • rheumatoid arthritis
  • rheumatoid arthritis patients
  • ankylosing spondylitis
  • juvenile idiopathic arthritis